HSF1 and B-cell chronic lymphocytic leukemia: In this context, we correlated HSP70 and HSF1 expression levels and response to Ibrutinib-containing regimen in CLL patients, demonstrating that these two molecules were overexpressed before or during progression in patients failing ibrutinib.